Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,309 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

NCT05641103

Conditions
ASMD, Acid Sphingomyelinase Deficiency, Brain Diseases, +25 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital de Poniente El Ejido, Almería, Spain
  • Hospital Universitario de Badajoz Badajoz, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
View all 14 locations
View Trial Details
Completed

Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease

NCT05843916

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Instituto de Nefrología Pergamino S.R.L Pergamino, Buenos Aires, Argentina
  • Centro Médico Santa María de la Salud San Isidro, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Quilmes Buenos Aires, Argentina
  • Clínica Universitaria Reina Fabiola Córdoba, Argentina
View Trial Details
Completed

A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

NCT05079919

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Accel Research Sites Network Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Velocity Clinical Research Chula Vista, California, United States
  • Diabetes/Lipid Management & Research Center Huntington Beach, California, United States
View all 209 locations
View Trial Details
Completed

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

NCT05610280

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Alabama Clinical Therapeutics, LLC Alabaster Birmingham, Alabama, United States
  • Heart Center Research PC Huntsville, Alabama, United States
  • Cardiovascular Research Foundation of Southern California Beverly Hills, California, United States
  • Westside Medical Associates of Los Angeles Beverly Hills, California, United States
View all 168 locations
View Trial Details
Completed

Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease

NCT04049760

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of South Florida Tampa, Florida, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • University of Minnesota Masonic Children's Hospital and Clinics Minneapolis, Minnesota, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details

Related conditions